StonvexLoading…
StonvexStonvexStonvexCore line items from RDZN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $38.90M | $24.54M | $10.87M | $44.30M |
Operating Income | $-8.22M | $-5.86M | $-2.52M | $-60.81M |
Net Income | $-15.26M | $-2.11M | $-4.01M | $-72.87M |
EPS (Diluted) | $-0.20 | $-0.08 | $-0.05 | $-1.04 |
Total Assets | $44.87M | $41.55M | $32.96M | $32.58M |
Total Liabilities | $68.95M | $62.40M | $61.75M | $58.27M |
Cash & Equivalents | $5.14M | $4.97M | $3.12M | $4.84M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $-18.57M |
Shares Outstanding | 79.50M | 76.02M | 74.29M | 74.29M |